Olema Oncology
Kristin Lowland Lanzi has extensive experience in IT leadership roles, starting as an Associate Project Manager at Sapient in 1999. Kristin then progressed to roles such as Project Manager at Digitas, IT Manager at Seagate Properties, Sr. IT Manager at Genentech, and Associate Director at Medivation. Their recent roles include Head of IT at Achaogen, VP of IT at Iovance Biotherapeutics, and currently as VP of IT at Olema Oncology. Through their career, Kristin has demonstrated strong skills in team management, project management, infrastructure upgrades, and IT operations.
Kristin Lowland Lanzi earned a Bachelor of Arts (BA) degree in Business and Political Science from California Polytechnic State University-San Luis Obispo in 1999. Kristin also holds a certification in ITIL Foundation.
This person is not in any teams
Olema Oncology
Olema Oncology is a biopharmaceutical company developing innovative targeted therapies for women’s cancers. Their lead program, OP-1250, a potential best-in-class complete estrogen receptor antagonist (CERAN), is in development to treat estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer. Olema recently initiated a Phase 1/2 dose-escalation and expansion clinical trial of OP-1250. They are supported in their mission by experienced and accomplished scientists and board members, leading healthcare investors and some of the most innovative pharma companies.